Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Alpha-1 inhibition. Knowledge and prospectives].

¹Laboratoire Pfizer, Paris.

Annales De Cardiologie Et D'Angeiologie

|December 30, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The relationship between wearable-derived sleep features and relapse in Major Depressive Disorder.

Journal of affective disorders·2024

Same author

COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study.

Respiratory medicine and research·2024

Same author

Study of the feasibility of outpatient sacrocolpopexy by laparoscopy.

Journal of gynecology obstetrics and human reproduction·2024

Same author

The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.

Annales de dermatologie et de venereologie·2024

Same author

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.

Cancer immunology, immunotherapy : CII·2023

Same author

Corrigendum to 'Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial: [Annals of Oncology Volume 32, Issue 10, October 2021, Pages 1276-1285].

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Same journal

[Study of Sleep Apnea Syndrome in Patients with Chronic Heart Failure in the Cardiology Department at Yalgado Ouédraogo teaching hospital in 2024 and 2025].

Annales de cardiologie et d'angeiologie·2026

Same journal

[Impact of knowledge and practices of hygieno-dietetical measures in hypertensive people at the Abidjan cardiology institute].

Annales de cardiologie et d'angeiologie·2026

Same journal

[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population].

Annales de cardiologie et d'angeiologie·2026

Same journal

[Dobutamine stress echocardiography: Appropriateness of indications and protocol compliance. A single-centre report].

Annales de cardiologie et d'angeiologie·2026

Same journal

[Post-COVID postural orthostatic tachycardia syndrome: Documentation of a hyperadrenergic phenotype by comprehensive autonomic testing].

Annales de cardiologie et d'angeiologie·2026

Same journal

Urban-rural disparities in hypertension prevalence, screening, and control in South Kivu Province, eastern Democratic Republic of the Congo.

Annales de cardiologie et d'angeiologie·2026

See all related articles

Alpha inhibitors like prazosin are effective arterial vasodilators for treating hypertension. A new formulation of prazosin is expected to broaden its therapeutic applications in managing high blood pressure.

Area of Science:

Cardiovascular Medicine
Pharmacology

Context:

Arterial hypertension is frequently characterized by increased vascular peripheral resistance.
Arterial vasodilators represent a key therapeutic strategy for managing hypertension.

Purpose:

To highlight the role of arterial vasodilators in managing hypertension.
To introduce prazosin, an alpha inhibitor, as a potent arterial vasodilator.
To suggest the potential of a new galenic form of prazosin for expanded therapeutic use.

Summary:

Increased vascular peripheral resistance is a primary hemodynamic alteration in arterial hypertension.
Prazosin, an alpha inhibitor, functions as a potent arterial vasodilator.
A novel galenic formulation of prazosin is anticipated to enhance its therapeutic efficacy and applicability.

Related Experiment Videos

Impact:

Prazosin's new formulation may offer improved treatment options for patients with arterial hypertension.
This advancement could lead to a wider therapeutic range for managing high blood pressure.
The study underscores the importance of vasodilators in cardiovascular pharmacotherapy.